It has been four years since the start of the COVID-19 pandemic. SARS-CoV-2 has yet to be eradicated and new variants are continuously emerging. Despite the extensive immunization programs, breakthrough infections (infection ...
Jan 19, 2024
1
57
Cytomegalovirus (CMV) is a pathogen that likes to lurk. Most adults already carry CMV, and they show no symptoms at all. The trouble comes when the virus infects a pregnant person for the first time and passes through the ...
Jan 19, 2024
0
19
The bitter winter elements can be brutal on the body. But is there any truth that you can "catch a cold" if not properly dressed outside?
Jan 18, 2024
0
0
Recent SARS-CoV-2 variants such as BA.4 and BA.5 developed abilities missing from the first omicron variants that allowed them to overcome humans' innate immunity, according to research from UCL.
Jan 16, 2024
0
39
The number of infections by the tick-borne TBE virus that are not detected by health services is far higher than previously assumed. This has been shown in a new study of Swedish blood donors from Uppsala University and the ...
Jan 12, 2024
0
1
People with long COVID have dysfunctional immune cells that show signs of chronic inflammation and faulty movement into organs, among other unusual activity, according to a new study by scientists at Gladstone Institutes ...
Jan 11, 2024
0
122
Mayo Clinic researchers have unraveled the molecular mechanisms that affect which cells infected with human immunodeficiency virus (HIV) die and which survive, a discovery heralded as a step toward eliminating all HIV-infected ...
Jan 11, 2024
0
13
Scientists have long known that some viruses and bacteria begin infections by latching first onto sugar molecules on the surfaces of cells lining the sinuses and throat of mammals, including humans. Viral particles, for instance, ...
Jan 11, 2024
0
6
Researchers at Karolinska Institutet have shown that nasal drops with IgA antibodies can protect mice from SARS-CoV-2 infection. The results imply a new way to protect individuals at high risk from different variants of the ...
Jan 10, 2024
0
147
The body's immune response to Epstein-Barr virus (EBV) may play a role in causing damage in people with multiple sclerosis, according to a new study led by University of Texas Health Houston.
Jan 8, 2024
0
25
